New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.
These molecules not only rapidly improve symptoms, but remarkably, also appear to renew the underlying brain impairments causing memory loss in preclinical models. These findings were presented today at the American Association for the Advancement of Science (AAAS) Annual Meeting in Washington DC.
“Currently there are no medications to treat cognitive symptoms such as memory loss that occur in depression, other mental illnesses and aging,” says Dr. Etienne Sibille, Deputy Director of the Campbell Family Mental Health Research Institute at CAMH and lead scientist on the study.
What’s unique and promising about these findings, in the face of many failures in drug development for mental illness, is that the compounds are highly targeted to activate the impaired brain receptors that are causing memory loss, he says.
It took a series of studies – the most recent appearing in January 2019 in Molecular Neuropsychiatry – to reach this stage. First, Dr. Sibille and his team identified the specific impairments to brain cell receptors in the GABA neurotransmitter system. Then they showed that these impairments likely caused mood and memory symptoms in depression and in aging.
The new small molecules were invented to bind to and activate this receptor target. The idea was that they would exert a therapeutic effect by “fixing” the impairment, resulting in an improvement in symptoms. The molecules are chemical tweaks of benzodiazepines, a class of anti-anxiety and sedative medications that also activate the GABA system, but are not highly targeted.
A single dose of these new molecules was administered in preclinical models of stress-induced memory loss. Thirty minutes later, memory performance returned to normal levels, an experiment that was reproduced more than 15 times. In another experiment involving preclinical models of aging, memory declines were rapidly reversed and performance increased to 80 per cent after administration, essentially reaching levels seen in youth or earlier stages of adulthood. This improvement lasted over two months with daily treatment.
“The aged cells regrew to appear the same as young brain cells, showing that our novel molecules can modify the brain in addition to improving symptoms,” says Dr. Sibille. He expects to start testing the molecules in clinical research in two years. “We’ve shown that our molecules enter the brain, are safe, activate the target cells and reverse the cognitive deficit of memory loss.”
If successful, the potential applications are broad. Not only is there a lack of treatment for cognitive deficits in mental illness, but the brain improvements suggest the molecules could help to prevent the memory loss at the beginning of Alzheimer’s disease, potentially delaying its onset.
The Latest on: Memory loss and depression
via Google News
The Latest on: Memory loss and depression
- PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorderson January 18, 2021 at 10:33 pm
(GLOBE NEWSWIRE) -- Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on ...
- How you can keep your mind sharp... and cut your risk of dementia: Try these tips and techniques from a fascinating new book by a top neurosurgeonon January 17, 2021 at 11:39 pm
When I began working as a neurosurgeon more than 25 years ago, the idea of improving your brain seemed a rather misguided one.
- Dana White and the UFC are exploring whether the use of psychedelics could help fighters deal with brain traumaon January 14, 2021 at 8:37 am
The UFC is exploring whether psychedelics could be used to help deal with brain trauma sustained by MMA fighters.
- Memory loss a lesser-known symptom of menopauseon January 14, 2021 at 5:21 am
Study suggests cognitive declines may begin as early as the perimenopause phase (the onset of menstrual irregularity).
- Dana White: Spencer Fisher ‘not the first and he’s definitely not going to be the last’ to deal with brain traumaon January 13, 2021 at 11:30 am
UFC president Dana White reacts to the recent revelations from retired fighter Spencer Fisher, who is now dealing with brain trauma issues after calling it a career seven years ago.
- Researchers identify and characterize three molecular subtypes of Alzheimer'son January 7, 2021 at 12:55 pm
Researchers at the Icahn School of Medicine at Mount Sinai have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing. The study advances our ...
- This Graphic Highlights That Anxiety and Depression Both Cause Memory Losson January 4, 2021 at 4:47 pm
Artist and comic @depressedgraph found an effective way to highlight that depression and anxiety can cause memory loss — a mental health symptom we don’t address often enough. Both anxiety ...
- Vitamin B12 deficiency: Could your depression, anxiety and insomnia be due to low levels?on December 29, 2020 at 12:36 pm
Having low levels of B12 may be linked to a number of psychiatric disorders including depression, memory loss, anxiety and schizophrenic symptoms. Cobalamin (Vitamin B12), a water-soluble ...
- Can depression cause memory loss?on December 15, 2009 at 4:00 am
This has happened three times in the past week alone. Is there a correlation between recurrent bouts of depression and memory loss? I would question the medications as a factor, but he has not ...
via Bing News